Published May 14, 2024
AI in Pharmaceutical R&D with Kim Branson
Kim Branson, GSK's SVP and Global Head of AI and Machine Learning, explores AI’s transformative impact on pharmaceutical R&D, emphasizing its role in revolutionizing drug discovery, leveraging unique data for competitive advantage, and integrating leadership strategies in corporate innovation.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
AI and Actionable Insights for Drug Development with Daphne Koller
Answers 383 questions
Adapting Biopharma to AI with Greg Meyers
Answers 383 questions
Adapting Biopharma to AI with Greg Meyers
Answers 383 questions
AI at the Intersection of Bio with Vijay Pande, Surya Ganguli, and Bowen Liu
Answers 383 questionsAdapting Biopharma to AI: A 2024 Update with Greg Meyers
Answers 383 questionsGrand Challenges in Healthcare AI with Vijay Pande and Julie Yoo
Answers 383 questionsBiotech Revolution with Software Engineering Daily
Answers 383 questions
AI + a16z with Vijay Pande
Answers 383 questionsAI is Here. Now What?
Answers 383 questionsExpert AI as a Healthcare Superpower
Answers 383 questions
The Intersection of Biotech x High Tech with Vineeta Agarwala
Answers 383 questions
Behind the Buy: Payors and Providers on AI Adoption
Answers 383 questionsThe Power of Drug Discovery with Philip Tagari
Answers 383 questions
The Transformative Power of AI in Science with Pushmeet Kohli
Answers 383 questions
Supercharging Discovery with Evan Feinberg
Answers 383 questions